SP1 and lung cancer: However, Sp1 downregulation in the late stages of lung cancer leads to a decrease in miR-182 expression, causing FOXO3-mediated tumor metastasis by increasing the expression of N-cadherin, ADAM9, CDH9, and CD44 [136].